Autoimmunity Reviews
ISSN 1568-9972 · Elsevier BV · Netherlands · active 1878–2026
Metrics
“Cites per paper” is a two-year cited-by rate computed from OpenAlex. It is not a Clarivate Journal Impact Factor — we neither compute nor license that metric. Citation rates differ enormously between fields, so compare within a discipline.
Indexing & access
Access status: unknown. Where this comes from publisher-level signals rather than works-level data it is a heuristic — confirm on the journal’s own site, especially regarding any article processing charge.
Scope
Frequently asked
Is Autoimmunity Reviews a predatory journal?
Our screening does not flag Autoimmunity Reviews. That is not a guarantee of quality — it means the venue is not on Beall's archive (frozen since 2017) and does not match our name-pattern heuristic. It is listed in Scopus, Web of Science, PubMed, which is a positive signal.
Is Autoimmunity Reviews indexed in Scopus or Web of Science?
Per our venue index, Autoimmunity Reviews appears in: Scopus, Web of Science, PubMed. Index membership changes over time — confirm on the index's own site before relying on it.
What is Autoimmunity Reviews's impact?
Papers in Autoimmunity Reviews are cited about 6.1 times each within two years of publication, and Scimago places it in Q1, with an h-index of 191. This is not a Clarivate Journal Impact Factor — we neither compute nor license that metric — and a citation rate is a property of a field as much as of a journal.
Is Autoimmunity Reviews open access?
We hold no reliable open-access classification for Autoimmunity Reviews. Check the journal's own site for its access model and any article processing charge.
Similar venues
- Nature Reviews Disease PrimersQ1 · Nature Portfolio
- Nature Reviews RheumatologyQ1 · Nature Portfolio
- Clinical Reviews in Allergy & ImmunologyQ1 · Springer Nature
- Journal of AutoimmunityQ1 · Elsevier BV
- The Lancet RheumatologyQ1 · Elsevier BV
- Current Rheumatology ReportsQ1 · Springer Science+Business Media